Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Dr. Shiller on Molecular Diagnostics in Gastrointestinal Cancers

Shirley Michelle Shiller, DO
Published: Tuesday, Oct 23, 2018



Shirley Michelle Shiller, DO, member of the Precision Medicine Institute's Advisory Committee, Baylor University Medical Center, discusses molecular diagnostics in gastrointestinal (GI) cancers.

The field of molecular diagnostics is moving rapidly in the paradigm of GI cancers, says Shiller. Though a lot of technologies are coming to market, there is not enough understanding of the strengths and weaknesses of each individual assay, adds Shiller. If a physician is unsure about whether a particular test will answer the question at hand, they should consult their pathologist.

Pathologists can help guide physicians to the best diagnostic test. The goal, says Shiller, is to provide the right test to the right patient at the right time. If this is done in a thoughtful and meaningful fashion, Shiller anticipates that physicians will not have as many issues with third-party payers down the line.


Shirley Michelle Shiller, DO, member of the Precision Medicine Institute's Advisory Committee, Baylor University Medical Center, discusses molecular diagnostics in gastrointestinal (GI) cancers.

The field of molecular diagnostics is moving rapidly in the paradigm of GI cancers, says Shiller. Though a lot of technologies are coming to market, there is not enough understanding of the strengths and weaknesses of each individual assay, adds Shiller. If a physician is unsure about whether a particular test will answer the question at hand, they should consult their pathologist.

Pathologists can help guide physicians to the best diagnostic test. The goal, says Shiller, is to provide the right test to the right patient at the right time. If this is done in a thoughtful and meaningful fashion, Shiller anticipates that physicians will not have as many issues with third-party payers down the line.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Navigating New Sequencing Challenges for the Treatment of Hepatocellular CarcinomaAug 30, 20191.5
Publication Bottom Border
Border Publication
x